Are drug patents worth it?
Politicians are attacking IP protection, but shareholders are Big Pharma’s bigger headache ONE OF THE first rules of American politics is not to pick a fight with Big Pharma. Its army of lobbyists in Washington, DC, has ensured that presidents from both parties, from Ronald Reagan to Barack Obama, have…
bubmagMay 13, 2021